Davide Verotta - Concepedia

Author

Davide Verotta

University of California, San Francisco ORCID

Also Known As

D VEROTTA, D Verotta, D. Verotta, Davide Verotta

110

Publications

3.2K

Citations

H-Index

117

Concepts

All Affiliations

University of California, San Francisco Stanford University San Francisco General Hospital NGM Biopharmaceuticals (United States)

About

Davide Verotta is an author at University of California, San Francisco specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	26	1.4K
2	Public Health	8	8	195
3	Engineering	7	7	211
4	Health Sciences	7	7	136
5	Social Sciences	2	2	269

Davide Verotta

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects Jaap W. Mandema, Davide Verotta, Lewis B. Sheiner Journal of Pharmacokinetics and Biopharmaceutics Pharmacokinetic ModelingPharmacodynamicsMedicinePopulation Pharmacokineticpharmacodynamic ModelsPharmacology	1992	493
Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man J. Schüttler, Donald R. Stanski, Paul F. White, Journal of Pharmacokinetics and Biopharmaceutics Pharmacokinetic ModelingNeurophysiologyEeg EffectsMedicineBehavioural Pharmacology	1987	178
Input Characteristics and Bioavailability after Administration of Immediate and a New Extended-release Formulation of Hydromorphone in Healthy Volunteers David R. Drover, Martin S. Angst, Marta Valle, Anesthesiology	2002	108
Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations Janice B. Schwartz, John C. Gallagher, Rolf Jorde, The Journal of Clinical Endocrinology & Metabolism	2018	97
Differential postnatal development of μ-, δ- and χ-opioid binding sites in rat brain Paola Petrillo, Alessandra Tavani, Davide Verotta, Developmental Brain Research Brain DevelopmentSynaptic TransmissionNeurotransmitterSynaptic SignalingSocial Sciences	1987	91
Comparative Tissue Concentration Profiles of Fentanyl and Alfentanil in Humans Predicted from Tissue/Blood Partition Data Obtained in Rats Sven Björkman, Donald R. Stanski, Davide Verotta, Anesthesiology PharmacotherapyExperimental PharmacologyPhysiologically-based Pharmacokinetic ModelingPharmacological StudyTerminal Half-life	1990	67
Gentamicin Pharmacokinetics and Dosing in Neonates with Hypoxic Ischemic Encephalopathy Receiving Hypothermia Adam Frymoyer, Lina Meng, Sonia L. Bonifacio, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2013	61
Pharmacodynamics of Acute Tolerance to Multiple Nicotinic Effects in Humans Karin Fattinger, Davide Verotta, Neal L. Benowitz Journal of Pharmacology and Experimental Therapeutics	1997	54
Population analyses of sustained‐release verapamil in patients: Effects of sex, race, and smoking Dong‐Woo Kang, Davide Verotta, M KRECICSHEPARD, Clinical Pharmacology & Therapeutics	2003	54
The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose Rebecca A. Boyd, Shu Chin, Oluta Don-Pedro, Clinical Pharmacology & Therapeutics	1989	51

Page 1